AMANDA WHEELER: Open Payments
NPI 1124861737 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,401 in 149 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $880 · 2025 $3,401
Food & beverage: $3,322Education: $79
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 30 | $646 |
| GENZYME CORPORATION | 14 | $400 |
| GlaxoSmithKline, LLC. | 18 | $313 |
| Regeneron Healthcare Solutions, Inc. | 13 | $306 |
| Grifols USA, LLC | 9 | $260 |
| Amgen Inc. | 13 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $224 |
| Viatris Specialty LLC | 10 | $199 |
| Verona Pharma, Inc. | 5 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $119 |
Products named: DUPIXENT, TEZSPIRE, Prolastin-C Liquid, GLASSIA, YUPELRI, AIRSUPRA, FASENRA, NUCALA.
Industry payments across AL — which companies pay providers there.
